Institutional Review Board assessment of risks and benefits associated with research

&
National Bioethics Advisory Commission 6705 Rockledge Drive, Suite 700, Bethesda, Maryland 20892-7979 Telephone: 301-402-4242• Fax: 301-480-6900• Website: Www. Bioethics. Gov (forthcoming)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,322

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Reasonable Risks In Clinical Research: A Critique and a Proposal for the Integrative Approach.Alex John London - unknown
Evaluating the Risks and Benefits of Phase II and III Cancer Clinical Trials: A Look at Institutional Review Board Members in the Netherlands.A. W. Musschenga, H. E. M. Van Luijn, N. K. Aaronson & R. B. Keus - unknown
The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study.H. E. M. van Luijn - 2006 - Journal of Medical Ethics 32 (3):170-176.
The Right to Participate in High-Risk Research.David Shaw - 2014 - The Lancet 38:1009 – 1011.
Understanding risks and benefits in research on reproductive genetic technologies.Janet Malek - 2007 - Journal of Medicine and Philosophy 32 (4):339 – 358.
When Are Research Risks Reasonable in Relation to Anticipated Benefits?Charles Weijer & Paul B. Miller - unknown
Limits to research risks.F. G. Miller & S. Jofe - 2009 - Journal of Medical Ethics 35 (7):445-449.
The concept of risk and responsible conduct of research.Eugenijus Gefenas - 2006 - Science and Engineering Ethics 12 (1):75-83.
The placebo phenomenon and medical ethics: Rethinking the relationship between informed consent and risk–benefit assessment.Franklin G. Miller & Luana Colloca - 2011 - Theoretical Medicine and Bioethics 32 (4):229-243.
Challenges in a Divided Assessment of the Social Benefits and Risks of Research.David Wasserman - 2011 - American Journal of Bioethics 11 (5):12-13.
Risk in Emergency Research Using a Waiver of/Exception from Consent: Implications of a Structured Approach for Institutional Review Board Review.Andrew D. McRae, Stacy Ackroyd-Stolarz & Charles Weijer - unknown
Internet research ethics and the institutional review board: current practices and issues.Elizabeth A. Buchanan & Charles M. Ess - 2009 - Acm Sigcas Computers and Society 39 (3):43-49.
Rethinking Local Institutional Review Board (IRB) Review at State Health Departments: Implications for a Consolidated, Independent Public Health IRB.David Perlman - 2012 - Journal of Law, Medicine and Ethics 40 (4):997-1007.
Institutional Barriers to Research on Sensitive Topics: Case of Sex Communication Research Among University Students.Carey M. Noland - 2012 - Journal of Research Practice 8 (1):Article - M2.

Analytics

Added to PP
2014-03-18

Downloads
36 (#429,312)

6 months
1 (#1,520,257)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Why the Debate over Minimal Risk Needs to be Reconsidered.Ariella Binik & Charles Weijer - 2014 - Journal of Medicine and Philosophy 39 (4):387-405.
Valuing risk: The ethical review of clinical trial safety.Jonathan Kimmelman - 2004 - Kennedy Institute of Ethics Journal 14 (4):369-393.

Add more citations

References found in this work

No references found.

Add more references